Gamma Investing LLC Ardelyx, Inc. Transaction History
Gamma Investing LLC
- $1.17 Trillion
- Q4 2024
A detailed history of Gamma Investing LLC transactions in Ardelyx, Inc. stock. As of the latest transaction made, Gamma Investing LLC holds 410 shares of ARDX stock, worth $2,086. This represents 0.0% of its overall portfolio holdings.
Number of Shares
410
Previous 427
3.98%
Holding current value
$2,086
Previous $2.94 Million
29.33%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ARDX
# of Institutions
218Shares Held
141MCall Options Held
1.08MPut Options Held
2M-
Janus Henderson Group PLC London, X021.5MShares$110 Million0.08% of portfolio
-
Black Rock Inc. New York, NY17.6MShares$89.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.6MShares$69.2 Million0.0% of portfolio
-
State Street Corp Boston, MA12.1MShares$61.8 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C38.95MShares$45.5 Million0.07% of portfolio
About ARDELYX, INC.
- Ticker ARDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 154,636,000
- Market Cap $787M
- Description
- Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...